Dendritic cell-based immunotherapy

被引：628
|
作者：
Sabado, Rachel L. [1 ]
Balan, Sreekumar [1 ]
Bhardwaj, Nina [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
来源：
CELL RESEARCH | 2017年 / 27卷 / 01期
关键词：
dendritic cell; immunotherapy; CERVICAL-CANCER PATIENTS; REGULATORY T-CELLS; INTEGRATED IMMUNE-RESPONSE; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IN-VIVO; SIPULEUCEL-T; LYMPH-NODES; LISTERIA-MONOCYTOGENES; ANTITUMOR IMMUNITY;
D O I：
10.1038/cr.2016.157
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.
引用
收藏
页码：74 / 95
页数：22
相关论文
共 50 条
  • [1] Dendritic cell-based immunotherapy
    Rachel L Sabado
    Sreekumar Balan
    Nina Bhardwaj
    Cell Research, 2017, 27 : 74 - 95
  • [2] Dendritic cell-based immunotherapy
    Osada, Takuya
    Clay, Timothy M.
    Woo, Christopher Y.
    Morse, Michael A.
    Lyerly, H. Kim
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2006, 25 (5-6) : 377 - 413
  • [3] Dendritic cell-based immunotherapy
    Berger, TG
    Schultz, ES
    DENDRITIC CELLS AND VIRUS INFECTION, 2003, 276 : 163 - 197
  • [4] Nanoparticles for dendritic cell-based immunotherapy
    Tuan Hiep Tran
    Thi Thu Phuong Tran
    Hanh Thuy Nguyen
    Cao Dai Phung
    Jeong, Jee-Heon
    Stenzel, Martina H.
    Jin, Sung Giu
    Yong, Chul Soon
    Duy Hieu Truong
    Kim, Jong Oh
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 542 (1-2) : 253 - 265
  • [5] DOCETAXEL DENDRITIC CELL-BASED IMMUNOTHERAPY
    Nakashima, Hiroshi
    Tasaki, Akira
    Kubo, Makoto
    Matsumoto, Kotaro
    Nakamura, Masafumi
    Tanaka, Masao
    Katano, Mitsuo
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3576 - 3576
  • [6] Dendritic cell-based immunotherapy of cancer
    Zitvogel, L
    Angevin, E
    Tursz, T
    ANNALS OF ONCOLOGY, 2000, 11 : 199 - 205
  • [7] Dendritic cell-based immunotherapy in mesothelioma
    Cornelissen, Robin
    Lievense, Lysanne A.
    Heuvers, Marlies E.
    Maat, Alexander P.
    Hendriks, Rudi W.
    Hoogsteden, Henk C.
    Hegmans, Joost P.
    Aerts, Joachim G.
    IMMUNOTHERAPY, 2012, 4 (10) : 1011 - 1022
  • [8] Tolerogenic dendritic cell-based immunotherapy
    Chang, Kiyuk
    Song, Jie-Young
    Lim, Dae-Seog
    ONCOTARGET, 2017, 8 (53) : 90630 - 90631
  • [9] Dendritic cell-based cancer immunotherapy
    Engleman, EG
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 23 - 29
  • [10] Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
    Song, Min-Seon
    Nam, Ji-Hee
    Noh, Kyung-Eun
    Lim, Dae-Seog
    JOURNAL OF IMMUNOLOGY RESEARCH, 2024, 2024
12345